Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 13, Number 2—February 2007


Characteristics of Staphylococcus aureus Infections, Chicago Pediatric Hospital

Preeti Jaggi*, Suzanne M. Paule†, Lance R. Peterson†, and Tina Q. Tan*Comments to Author 
Author affiliations: *Northwestern University, Chicago, Illinois, USA; †Evanston Northwestern Healthcare, Evanston, Illinois, USA;

Main Article

Table 2

Susceptibility data for CA-MRSA isolates from children*

Susceptibility to antimicrobial agent†CA-MRSA isolates causing invasive disease, n (%)CA-MRSA isolates causing local skin/soft tissue infections, n (%)p value
Resistant to erythromycin16/18 (88.9)11/18 (61)NS
Apparently susceptible to clindamycin18/18 (100)18/18 (100)NS
Inducible clindamycin resistance3/16 (19)0/10 (0)NS
Resistant to ciprofloxacin2/18 (11)1/18 (6)NS
Resistant to levofloxacin1/18 (6)1/18 (6)NS
Resistant to tetracycline1/18 (5)2/18 (11)NS

*CA-MRSA, community-associated methicillin-resistant Staphylococcus aureus; NS, not significant.
†In addition to the antimicrobial agents listed, all isolates were susceptible to vancomycin, linezolid, and rifampin.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO